STAT3β is a tumor suppressor in acute myeloid leukemia.
Journal
Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425
Informations de publication
Date de publication:
09 07 2019
09 07 2019
Historique:
received:
21
09
2018
accepted:
04
05
2019
entrez:
5
7
2019
pubmed:
5
7
2019
medline:
10
7
2020
Statut:
ppublish
Résumé
Signal transducer and activator of transcription 3 (STAT3) exists in 2 alternatively spliced isoforms, STAT3α and STAT3β. Although truncated STAT3β was originally postulated to act as a dominant-negative form of STAT3α, it has been shown to have various STAT3α-independent regulatory functions. Recently, STAT3β gained attention as a powerful antitumorigenic molecule in cancer. Deregulated STAT3 signaling is often found in acute myeloid leukemia (AML); however, the role of STAT3β in AML remains elusive. Therefore, we analyzed the
Identifiants
pubmed: 31270081
pii: bloodadvances.2018026385
doi: 10.1182/bloodadvances.2018026385
pmc: PMC6616266
doi:
Substances chimiques
Biomarkers
0
STAT3 Transcription Factor
0
Tumor Suppressor Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1989-2002Informations de copyright
© 2019 by The American Society of Hematology.
Références
Blood. 2001 Dec 15;98(13):3853-6
pubmed: 11739197
Blood. 2002 Jan 1;99(1):252-7
pubmed: 11756179
Blood. 2011 May 26;117(21):5701-9
pubmed: 21447830
Cell Res. 2008 Feb;18(2):254-67
pubmed: 18227858
Front Oncol. 2015 Jun 08;5:121
pubmed: 26106584
Cancer Res. 2001 Apr 15;61(8):3276-80
pubmed: 11309279
Blood. 2001 Apr 1;97(7):2121-9
pubmed: 11264180
J Biol Chem. 1996 May 31;271(22):13221-7
pubmed: 8675499
Nat Rev Cancer. 2014 Nov;14(11):736-46
pubmed: 25342631
Stem Cells. 2014 May;32(5):1313-22
pubmed: 24446131
Leukemia. 1997 Sep;11(9):1469-77
pubmed: 9305600
Mol Cell Biol. 1997 Sep;17(9):5307-16
pubmed: 9271408
Mol Med Rep. 2009 Sep-Oct;2(5):819-24
pubmed: 21475907
Cell. 1995 Jul 28;82(2):241-50
pubmed: 7543024
Gene Ther. 2015 Dec;22(12):977-83
pubmed: 26181625
Hematology. 2011 Jul;16(4):232-5
pubmed: 21756540
Cancer Res. 1999 Oct 15;59(20):5059-63
pubmed: 10537273
Front Biosci. 2008 May 01;13:6501-14
pubmed: 18508676
Int J Hematol. 2005 Aug;82(2):93-9
pubmed: 16146838
Cell. 2004 Jul 23;118(2):217-28
pubmed: 15260991
Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17779-84
pubmed: 22006329
Blood. 1996 Mar 15;87(6):2496-505
pubmed: 8630416
Leukemia. 2006 Jun;20(6):971-8
pubmed: 16598306
Leukemia. 1995 May;9(5):869-74
pubmed: 7539515
Blood. 2013 Feb 14;121(7):1083-93
pubmed: 23243289
J Biol Chem. 2000 Oct 13;275(41):32244-9
pubmed: 10915797
Nat Immunol. 2004 Apr;5(4):401-9
pubmed: 15021879
Clin Cancer Res. 2016 Feb 1;22(3):691-703
pubmed: 26405196
Exp Oncol. 2014 Mar;36(1):50-1
pubmed: 24691286
Blood. 1998 Nov 1;92(9):3115-22
pubmed: 9787146
Nature. 2006 May 25;441(7092):518-22
pubmed: 16633340
Cytokine. 2004 Apr 21;26(2):45-56
pubmed: 15050604
Acta Haematol. 1997;97(1-2):22-8
pubmed: 8980607
Cancers (Basel). 2014 Jul 03;6(3):1408-40
pubmed: 24995504
Sci Rep. 2015 Dec 03;5:17663
pubmed: 26631279
Acta Haematol. 1997;97(1-2):53-62
pubmed: 8980610
Cancer Res. 2009 Apr 15;69(8):3510-9
pubmed: 19351839
Mol Cell Biol. 2001 Mar;21(5):1621-32
pubmed: 11238899
Blood. 2009 Dec 3;114(24):5034-43
pubmed: 19808698
Eur J Haematol. 1999 Sep;63(3):192-201
pubmed: 10485274
Blood. 1998 Oct 1;92(7):2322-33
pubmed: 9746770
Cytokine. 2017 Oct;98:42-50
pubmed: 28579221
Blood. 1994 Aug 15;84(4):1249-56
pubmed: 7519478
Biochem J. 2012 Oct 1;447(1):125-36
pubmed: 22799634
Biotechniques. 2007 Nov;43(5):659-60, 662, 664
pubmed: 18072595
Cancer Cell. 2008 Oct 7;14(4):335-43
pubmed: 18835035
Oncogene. 2002 Feb 7;21(7):1038-47
pubmed: 11850821
Clin Cancer Res. 2010 Jul 15;16(14):3721-33
pubmed: 20525753
JAKSTAT. 2012 Apr 1;1(2):65-72
pubmed: 24058752
Blood. 2017 Jan 26;129(4):424-447
pubmed: 27895058
Expert Rev Hematol. 2015 Feb;8(1):29-41
pubmed: 25374305
Blood. 2003 Apr 15;101(8):3164-73
pubmed: 12468433
Drug Resist Updat. 2009 Jun;12(3):81-9
pubmed: 19467916
Eur J Haematol. 2003 Nov;71(5):366-76
pubmed: 14667200
ChemMedChem. 2016 Apr 19;11(8):795-801
pubmed: 26662504
Leuk Res. 2001 Jun;25(6):473-82
pubmed: 11337019
J Biol Chem. 2007 Nov 30;282(48):34958-67
pubmed: 17855361
Exp Oncol. 2014 Dec;36(4):252-7
pubmed: 25537219
Nat Biotechnol. 1997 Sep;15(9):859-65
pubmed: 9306400
Nature. 2006 May 25;441(7092):475-82
pubmed: 16598206
Clin Cancer Res. 2003 Jun;9(6):2140-50
pubmed: 12796379
Blood. 2017 May 4;129(18):2587-2591
pubmed: 28258055
Leukemia. 1993 Aug;7(8):1174-9
pubmed: 8350618
Mol Cell. 2001 Mar;7(3):517-28
pubmed: 11463377
Cancer Cell. 2014 Aug 11;26(2):207-21
pubmed: 25065853
J Clin Invest. 2001 Feb;107(3):351-62
pubmed: 11160159